About: Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2000 (uk) im Mai 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2000 (ast) scientific article published on 01 May 2000 (en)
publication date	wds:Q73837093-CD85EE84-2AD1-4A34-961C-305C335F2DB2
publication date	2000-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73837093-962C0D60-6088-4720-901E-666B6BEBEA01
language of work or name	English
cites work	wds:Q73837093-04D71612-FA63-456D-9920-3179D14507EF wds:Q73837093-0C2951CF-3FFB-48BE-9917-B64B8ED3148F wds:Q73837093-17ABC544-8903-4F3C-B71C-0C4AE0F2D3F7 wds:Q73837093-3C22DCDD-9E90-4BE2-8EFF-A4BC2F046521 wds:Q73837093-53B86FD0-6C91-4DB5-9CD3-9E92D94E43DF wds:Q73837093-5860A39F-5E9E-423A-8793-F5BB947295F9 wds:Q73837093-59FB1B10-5FD1-4CAA-9AAC-5774EBE66BE5 wds:Q73837093-698421BA-817B-4D80-808E-F3B33B1F73CB wds:Q73837093-729EE894-E08D-4359-9328-7225D2F1DED7 wds:Q73837093-7C0B439B-0A4A-4EF5-B017-81E79524C591 wds:Q73837093-82304BDE-CD42-4F09-BEF0-BCC9D599C774 wds:Q73837093-8D9DC0FC-9D99-404D-8B6D-F9BC16EA1A43 wds:Q73837093-A0FEA64A-AB70-4B32-BAEF-BC75C4570775 wds:Q73837093-A5DBAAED-2CBC-4D43-8136-75816EC725B2 wds:Q73837093-A821C053-E484-484D-BAF2-EDC40C7FBBB7 wds:Q73837093-A8ABE2F5-84BC-43F0-8928-2044A7EC7AF8 wds:Q73837093-AA217C34-131D-4DB2-AEE5-B620B1C4824E wds:Q73837093-AEBDC484-B38C-4D17-9436-6470ED030D3C wds:Q73837093-BDDEBB65-931A-435B-B65C-71F47CF82959 wds:Q73837093-CDD190C1-1524-44D1-AEB8-758EE6438988 wds:Q73837093-CF24DEB7-5B76-42CB-97D4-7D6497394653 wds:Q73837093-DB0E9CD0-091A-4D4E-8455-1F887BCE81D0 wds:Q73837093-DB224E41-0476-4E77-A9B7-C257559F756D wds:Q73837093-E08E9E8D-C917-43FB-AC29-ACE344C29DF8 wds:Q73837093-E7EEEF1D-0707-4AEB-BE31-4AC9998B7E1B wds:Q73837093-F19C4778-9252-456C-87EF-6FDE368457A7 wds:Q73837093-F630B688-9732-4C40-9652-0146207103ED
cites work	A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes A comparison of reteplase with alteplase for acute myocardial infarction Trial of early nifedipine in acute myocardial infarction: the Trent study Nifedipine. Dose-related increase in mortality in patients with coronary heart disease Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study The effect of diltiazem on mortality and reinfarction after myocardial infarction wd:Q28360048 The risk of myocardial infarction associated with antihypertensive drug therapies TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial Beta blockade during and after myocardial infarction: an overview of the randomized trials A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II) Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators Diltiazem. A reappraisal of its pharmacological properties and therapeutic use. Long-term follow-up after early intervention with intravenous diltiazem or intravenous nitroglycerin for unstable angina pectoris Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction The pharmacological basis and pathophysiological significance of the heart rate-lowering property of diltiazem Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group Electrocardiographic correlates of reperfusion status after thrombolysis: is the "incomplete" or "interrupted" infarction a non-Q-wave infarction? Pharmacokinetic and bioavailability of diltiazem sustained-release: influence of food and time of administration. Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evalu
author name string	wds:Q73837093-0B470FA4-B723-430F-8DF6-A09690ABBA0B wds:Q73837093-1124E708-CDA3-47FA-A386-7393F4E773D6 wds:Q73837093-1B6F6B38-4812-49BA-B7CC-1EA70D0ABE2C wds:Q73837093-2F00CF02-A366-4DBD-A7DC-828C9E35FA6E wds:Q73837093-4D119C82-DA21-4928-8AA7-B09871A0036E wds:Q73837093-76D9715A-8391-444C-BE52-C05B8F70EFCB wds:Q73837093-95B4C394-9A3C-4BA7-B03C-4BCA9B74DE41 wds:Q73837093-BB4F3EEC-6ABB-4BF6-8D4E-505CD4590B75 wds:Q73837093-C38B9CEB-E10F-4F75-BA58-4A999751AF6D wds:Q73837093-EC5EBA72-4D36-49A2-B0AA-EC5C71EA4D21 wds:Q73837093-F99BFFFA-210E-44ED-8079-175FDE7B3546 wds:Q73837093-FA497134-2BBC-4DE4-B802-07F092099C4D wds:Q73837093-FB9B3037-C001-4B7D-849D-3CA6842989C2
author name string	K M Fox M F Carlier D G Julian K I Lie I R Starkey W H van Gilst A Whitehead M E Bertrand W E Boden O L Pedersen R G Scheldewaert J J Col J P Santoni
rdfs:label	Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (nl) Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT) (en)
skos:prefLabel	Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (nl) Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT) (en)
name	Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (nl) Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT) (en)
title	wds:Q73837093-3C54C6D1-0698-4C98-BFDC-0503C1B5C33B
title	Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT) (en)
page(s)	wds:Q73837093-E7E5C91D-804E-4888-9E74-D076A41B0AE0
page(s)	1751-1756

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software